The most commonly reported side effects of berdazimer include application site pain, application site erythema, and application site pruritus, based on 19 FDA adverse event reports from 2025 to 2025.
Percentages show how often each reaction appears relative to total reports for berdazimer.
These are voluntary reports and do not establish that berdazimer caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
42.1% of berdazimer adverse event reports involve female patients and 10.5% involve male patients. The largest age group is child at 100%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking berdazimer when the adverse event was reported.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.